TEXAS RESEARCH INSTITUTE , AUSTIN, INC. — Department of Defense SBIR Phase II: DHA SBIR DIRECT TO PHASE II TOPIC DHA233-D001 PROPOSAL H2D-0146 TITLED TYPE IV MEDICAL OXY

TEXAS RESEARCH INSTITUTE , AUSTIN, INC. — SBIR Phase II award from Department of Defense.

Phase II SBIR prototype / development signal

  • Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
  • Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
  • Obligated amount $1,299,999 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
  • Tagged technology areas: Materials & Manufacturing, Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.

Informational capture context from public federal data — not legal or bid advice.

Summary

Texas Research Institute Austin Inc. won a $1.3 million Phase II SBIR award from the Defense Health Agency to develop a Type IV medical oxygen storage cylinder. The project focuses on creating a lightweight, advanced composite cylinder for safer and more efficient oxygen storage in military medical settings.

Amount
$1,299,999
Agency
Department of Defense · Defense Health Agency
Program / Phase
SBIR · Phase II
NAICS
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Place of performance
TX
Period
2024-03-13 → 2027-07-12

Technology domains

Materials & Manufacturing Human Performance & Medical

Description

DHA SBIR DIRECT TO PHASE II TOPIC DHA233-D001 PROPOSAL H2D-0146 TITLED TYPE IV MEDICAL OXYGEN STORAGE CYLINDER LOG NUMBER 23000574

View on USASpending.gov ↗